Table: begin end state 1 20 signal peptide 21 28 non-cytoplasmic 29 47 transmembrane 48 57 cytoplasmic 58 78 transmembrane 79 85 non-cytoplasmic 86 103 transmembrane 104 109 cytoplasmic 110 130 transmembrane 131 154 non-cytoplasmic 155 178 transmembrane 179 257 cytoplasmic 258 278 transmembrane 279 284 non-cytoplasmic 285 304 transmembrane 305 323 cytoplasmic 324 349 transmembrane 350 355 non-cytoplasmic 356 374 transmembrane 375 400 cytoplasmic 401 421 transmembrane 422 423 non-cytoplasmic 424 441 transmembrane 442 475 cytoplasmic 476 501 transmembrane 502 506 non-cytoplasmic 507 530 transmembrane 531 536 cytoplasmic 537 562 transmembrane 563 567 non-cytoplasmic 568 591 transmembrane 592 603 cytoplasmic 604 628 transmembrane 629 633 non-cytoplasmic 634 656 transmembrane 657 661 cytoplasmic 662 682 transmembrane 683 790 non-cytoplasmic 791 810 transmembrane 811 827 cytoplasmic
Input: >SM_b20291 FitnessBrowser__Smeli:SM_b20291 MAWSLFQLWYASPLPFVFGFGILNDTEARAIHLGFALFLTFLAYPALKSSPRDRVPLADW VLGALGAFAGAYLFLFYGELAGRPGQPSTLDLVTGTAGILLLLEATRRALGLPMVFVAGV FIFYTFAGQYMPDVIQHRGASLVKFINHQWLTTEGVFGIALGVSTSFVFLFVLFGTLLEK AGAGNWMMQISIALLGHLRGGPAKVAVVSSALNGVVSGSSVSNVVSGGIFTIPLMKRTGL SGVKAGAIEASASINGQIMPPVMGAAAFLMVEYVGIPYSEIVKHALLPAVFSYIALLYMV HLEAVKLNMQPIPQRPTPMRERWLRMGLGLAGSVLAICLLYYGIIAIRAAFGESAPLLLA IAGVALYIATIWYSSRYPDLELDDPDAPILELPRAWDVTRTGLDFLIPIVVLLWCLMVEQ LSPGLSAFWATLTIIAIVATRKPLMAIFRKEDVAGSVRAAAWDLTDGLALGARNMIGIAV ATATAGIVVGTITLTGLGLMMTELVEFISGGNVIMMLILIAAISLVLGMGIPTTANYILV ATLMAPVVVELGSQAGLAIPLIAVHLFVFYFGIMADITPPVGLAAFAAAAISKEDPIATG FQGALYSLRTAILPFVFIFNPAILLIGVDTWAHTIWVAAISLAAILIFSAATMNWFVTKS RLWESAVLLLVCFTLFRPDWWLNQISPPYEELPASEFLRAVEEAPAKSRINFVVQGFDLM GDEVRKTVNVPLGEPGEPLQRLQSIGLTVTPAGESLMISNVDFGSYAKRIGLDVGFDIVA VLRKAEQPSSAIPVGIALAVTAGIAGLQFARKRADRSEAGLTGAARK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server